FDA Reveals Plan To Speed Up Generic Drug Review

Law360, New York (October 4, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration has unveiled a new program designed to speed up the process of getting generic drugs approved and to hasten the market entry of the less expensive generics.

The program - Generic Initiative for Value and Efficiency, or GIVE - revealed Thursday, aims to make the generic drug review process at the FDA significantly more productive in response to increases in the number of generic drug applications filed with the FDA.

The agency said it had approved or tentatively approved 682...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.